Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Si-Bone Inc (NQ: SIBN ) 16.62 +0.31 (+1.90%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Si-Bone Inc < Previous 1 2 3 Next > Analyst Ratings For SI-BONE August 06, 2024 Via Benzinga These Analysts Cut Their Forecasts On SI-BONE Following Q2 Results August 06, 2024 Via Benzinga SIBN Stock Earnings: SI-BONE Beats EPS, Beats Revenue for Q2 2024 August 05, 2024 SIBN stock results show that SI-BONE beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace 7 Leading MedTech Stocks for Next-Gen Health Solutions July 31, 2024 With healthcare innovations promising to deliver groundbreaking solutions, these MedTech stocks should be on your radar. Via InvestorPlace A Closer Look at 6 Analyst Recommendations For SI-BONE May 07, 2024 Via Benzinga SIBN Stock Earnings: SI-BONE Beats EPS, Beats Revenue for Q1 2024 May 06, 2024 SIBN stock results show that SI-BONE beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace Peeling Back The Layers: Exploring SI-BONE Through Analyst Insights March 28, 2024 Via Benzinga Beyond The Numbers: 4 Analysts Discuss SI-BONE Stock February 27, 2024 Via Benzinga Recap: SI-BONE Q4 Earnings February 26, 2024 Via Benzinga SI-BONE's Earnings Outlook February 23, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session May 06, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session February 27, 2024 Via Benzinga Where SI-BONE Stands With Analysts November 07, 2023 Via Benzinga Earnings Scheduled For November 6, 2023 November 06, 2023 Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million. Via Benzinga Analyst Ratings for SI-BONE September 26, 2023 Via Benzinga Analyst Ratings for SI-BONE August 08, 2023 Via Benzinga Earnings Preview: SI-BONE August 04, 2023 Via Benzinga The Latest Analyst Ratings for SI-BONE July 19, 2023 Via Benzinga Why Shares of Si-Bone Jumped Tuesday May 02, 2023 The company reported first-quarter earnings and improved revenue guidance. Via The Motley Fool Canaccord Genuity Maintains Buy Rating for SI-BONE: Here's What You Need To Know May 02, 2023 Via Benzinga Earnings Scheduled For February 26, 2024 February 26, 2024 Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.23 per share on revenue of $477.73 million. Via Benzinga What Analysts Are Saying About SI-BONE Stock December 22, 2023 Via Benzinga What 5 Analyst Ratings Have To Say About SI-BONE December 04, 2023 Via Benzinga Cantor Fitzgerald Maintains Overweight Rating for SI-BONE: Here's What You Need To Know November 07, 2023 Via Benzinga SI-BONE Poised For A Surge: Analyst Highlights Upside Potential With New Product Launches July 12, 2023 Needham analyst David Saxon reiterated a Buy rating on SI-BONE, Inc (NASDAQ: SIBN), Via Benzinga Market Rally Finishes Strong; Regional Banks, Fed Rate Hike, Jobs Report, Apple In Focus: Weekly Review May 05, 2023 The major indexes retreated for most of the week on banking fears, Via Investor's Business Daily The Latest Analyst Ratings for SI-BONE May 02, 2023 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session May 05, 2023 Via Benzinga US Stocks Down; Chegg Crashes After Removing Guidance On ChatGPT Concerns May 02, 2023 U.S. stocks traded lower this morning even as the Federal Reserve’s two-day meeting began. Following the market opening Tuesday, the Dow traded down 0.47% to 33,891.31 while the NASDAQ fell 0.12% to... Via Benzinga Earnings Scheduled For May 1, 2023 May 01, 2023 Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterly loss at $0.37 per share on revenue of $3.38 million. Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.